TTM
$14.37
YoY change
+88.2%
5Y CAGR
+2.9%
Peak year (2025)
$14.23
Latest annual
$14.23
EPS (Diluted) history chart for Amgen (AMGN) from 1985 to 2025
Latest: $14.23
EPS (Diluted) growth chart for Amgen (AMGN) from 1985 to 2025
Latest: +88.2%
EPS (Diluted) history table for Amgen (AMGN) from 1985 to 2025
| 2025 | $14.23 | +88.2% | +$6.67 | ||
| 2024 | $7.56 | -39.5% | −$4.93 | ||
| 2023 | $12.49 | +3.1% | +$0.38 | ||
| 2022 | $12.11 | +17.8% | +$1.83 | ||
| 2021 | $10.28 | -16.5% | −$2.03 | ||
| 2020 | $12.31 | -4.4% | −$0.57 | ||
| 2019 | $12.88 | +2.1% | +$0.26 | ||
| 2018 | $12.62 | +369.1% | +$9.93 | ||
| 2017 | $2.69 | -73.7% | −$7.55 | ||
| 2016 | $10.24 | +13.0% | +$1.18 | ||
| 2015 | $9.06 | +35.2% | +$2.36 | ||
| 2014 | $6.70 | +0.9% | +$0.06 | ||
| 2013 | $6.64 | +20.3% | +$1.12 | ||
| 2012 | $5.52 | +36.6% | +$1.48 | ||
| 2011 | $4.04 | -15.7% | −$0.75 | ||
| 2010 | $4.79 | +6.2% | +$0.28 | ||
| 2009 | $4.51 | +19.6% | +$0.74 | ||
| 2008 | $3.77 | +33.7% | +$0.95 | ||
| 2007 | $2.82 | +13.7% | +$0.34 | ||
| 2006 | $2.48 | -15.4% | −$0.45 | ||
| 2005 | $2.93 | +61.9% | +$1.12 | ||
| 2004 | $1.81 | +7.1% | +$0.12 | ||
| 2003 | $1.69 | -239.7% | +$2.90 | ||
| 2002 | −$1.21 | -217.5% | −$2.24 | ||
| 2001 | $1.03 | -1.9% | −$0.02 | ||
| 2000 | $1.05 | +2.9% | +$0.03 | ||
| 1999 | $1.02 | +24.4% | +$0.20 | ||
| 1998 | $0.82 | +39.0% | +$0.23 | ||
| 1997 | $0.59 | -3.3% | −$0.02 | ||
| 1996 | $0.61 | +29.8% | +$0.14 | ||
| 1995 | $0.47 | +67.9% | +$0.19 | ||
| 1994 | $0.28 | -20.0% | −$0.07 | ||
| 1993 | $0.35 | +12.9% | +$0.04 | ||
| 1992 | $0.31 | +244.4% | +$0.22 | ||
| 1991 | $0.09 | +200.0% | +$0.06 | ||
| 1990 | $0.03 | — | — | ||
| 1988 | −$0.01 | -655.6% | −$0.01 | ||
| 1987 | $0.00 | +100.0% | +$0.00 | ||
| 1986 | $0.00 | 0.0% | $0.00 | ||
| 1985 | $0.00 | — | — |
- 2025$14.23+88.2%
- 2024$7.56-39.5%
- 2023$12.49+3.1%
- 2022$12.11+17.8%
- 2021$10.28-16.5%
- 2020$12.31-4.4%
- 2019$12.88+2.1%
- 2018$12.62+369.1%
- 2017$2.69-73.7%
- 2016$10.24+13.0%
- 2015$9.06+35.2%
- 2014$6.70+0.9%
- 2013$6.64+20.3%
- 2012$5.52+36.6%
- 2011$4.04-15.7%
- 2010$4.79+6.2%
- 2009$4.51+19.6%
- 2008$3.77+33.7%
- 2007$2.82+13.7%
- 2006$2.48-15.4%
- 2005$2.93+61.9%
- 2004$1.81+7.1%
- 2003$1.69-239.7%
- 2002−$1.21-217.5%
- 2001$1.03-1.9%
- 2000$1.05+2.9%
- 1999$1.02+24.4%
- 1998$0.82+39.0%
- 1997$0.59-3.3%
- 1996$0.61+29.8%
- 1995$0.47+67.9%
- 1994$0.28-20.0%
- 1993$0.35+12.9%
- 1992$0.31+244.4%
- 1991$0.09+200.0%
- 1990$0.03—
- 1988−$0.01-655.6%
- 1987$0.00+100.0%
- 1986$0.000.0%
- 1985$0.00—
EPS (Diluted) values are taken from Amgen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's current diluted EPS (TTM) is $14.37. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Amgen (AMGN) diluted EPS totalled $14.23 – surged 88.2% year-over-year.
Across 2020–2025 (5 years), Amgen diluted EPS produced a CAGR of +2.9% – with mixed annual results across the window.
The highest annual diluted EPS of $14.23 was reported in 2025. The lowest in the available history was −$1.21 in 2002.
Amgen EPS (Diluted) by Year
Amgen EPS (Diluted) 2025: $14.23
In 2025, Amgen reported diluted EPS of $14.23, surged 88.2% from 2024. This figure represents the highest annual value in the available history.
Amgen EPS (Diluted) 2024: $7.56
Amgen diluted EPS in 2024 was $7.56, plunged 39.5% below 2023.
Amgen EPS (Diluted) 2023: $12.49
2023's diluted EPS for Amgen came in at $12.49, edged up 3.1% from 2022.
Amgen EPS (Diluted) 2022: $12.11
Amgen posted diluted EPS of $12.11 in 2022, grew 17.8% from 2021.
Amgen EPS (Diluted) 2021: $10.28
Amgen diluted EPS in 2021 was $10.28.
See more financial history for Amgen (AMGN). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Amgen (AMGN), ranked by their latest diluted EPS
| $22.95 | |
| $17.74 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation